Impact of Anemia and Its Treatment on Gut Injury in Preterm Infants
Impact of Anemia and Its Treatment on Gut Injury in Preterm Infants
批准号:
10914515
负责人:
CASSANDRA D JOSEPHSON
金额:
$64.26万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-09-11 至 2024-05-31
关键词:
Adverse effectsAnemiaBirthBloodCause of DeathClinicalCoupledDataDevelopmentEpitheliumErythrocyte TransfusionErythrocytesErythroidErythropoiesisExcisionExhibitsFABP2 geneFunctional disorderHIF1A geneHemoglobinHypoxiaHypoxia Inducible FactorImmuneImpairmentInfantInflammationInflammatoryInjuryInterferon Type IIInterventionIntestinal DiseasesIntestinesInvestigationLeadLeukocyte L1 Antigen ComplexMacrophageMacrophage ActivationMeasuresMesenteryMusNear-Infrared SpectroscopyNecrotizing EnterocolitisNeonatalNeonatal AnemiaObservational StudyOxygenPlasmaPre-Clinical ModelPremature BirthPremature InfantProductionProspective cohortProspective, cohort studyReportingRiskRoleSafetySerumTestingTissuesTransfusionUmbilical Cord BloodVenous blood samplingWeldingcytokineextreme prematuritygut inflammationhigh riskimmune functionindividual variationinsightintestinal barrierintestinal injurymonocytemouse modelneonatal immunityneonatal miceneonatenovelpre-clinicalpreterm newbornprogenitorprospectiverecombinant human erythropoietinresponseurinary
中文摘要
摘要:新生儿贫血的治疗在很大程度上是基于测量的血红蛋白浓度(Hb)。
从历史上看,新生儿科医生开发了一种保守的血液管理方法,使用较低的Hb阈值
来触发输血。然而,我们最近的多中心前瞻性队列调查表明
早产儿严重贫血(Hb≤8g/dL)与坏死性小肠结肠炎的发生有关
NEC是一种严重的肠道疾病,也是早产儿死亡的主要原因。我们的长期目标是
确定调节贫血引起的新生儿免疫改变的关键机制,这些改变有助于肠道
炎症和损伤,因此可能使新生儿易患炎症性疾病,如NEC。我们的中央
假说是贫血引起的免疫抑制红系祖细胞(IEP)的变化
低氧引起的炎症可以不同程度地影响肠道的免疫功能,直接导致
新生儿肠道损伤,可能引起NEC。我们的假设是根据我们最近的发现提出的。
根据近红外线的测量,早产儿的严重贫血会导致肠道氧合功能受损。
光谱分析(NIRS),并显著升高血清促炎干扰素-γ(IFNG)水平。
使用临床前模型,我们的数据还表明,贫血通过肠道驱动IFNG的产生
诱导肠道损伤的巨噬细胞,这与先前的研究表明IFNG可以
直接损害上皮屏障功能。重要的是,贫血也会导致红血球的发生。
祖细胞,它不仅具有促进红细胞(RBC)产生的能力,而且还
似乎具有内在的免疫抑制作用。与此一致的是,从脐带血中分离出的免疫球蛋白具有
抑制巨噬细胞激活的能力,而在我们的临床前模型中移除IEP会加剧贫血-
诱导肠道巨噬细胞活化和肠道损伤。综上所述,这些结果表明,个人
低Hb值引起的低氧反应的变化,以及贫血诱导的IEP数量的变化
和功能,造成失衡,改变局部巨噬细胞活动,导致肠道中不同的反应,
使新生儿容易发生肠道炎症,并使他们面临较高的NEC风险。为了测试我们的中央
假设,我们将追求以下具体目标:目标1:确定贫血与其
治疗对IEP数量和功能的影响及其与血清细胞因子、促炎单核细胞的关系
分化,以及肠道氧合、炎症和损伤的标志物。目标2:确定
贫血诱导的IEPs对巨噬细胞促炎细胞因子分泌、肠道炎症和损伤的影响
在临床前模型中遵循不同的贫血阈值、持续时间和治疗方法。我们认为这些目标
提供一个独特的机会来确定调节贫血引起的肠道改变的关键因素
炎症和损伤。在这样做的过程中,这些数据具有提供对全球
贫血对新生儿肠道损伤的免疫影响可能有助于NEC的发生。
英文摘要
Summary: Treatment of neonatal anemia is largely based on measured hemoglobin concentrations (Hb).
Historically, neonatologists developed a conservative approach to blood management, using lower Hb thresholds
to trigger transfusions. However, our recent multicenter prospective cohort investigation demonstrated that
significant anemia in preterm infants (Hb ≤8g/dL) is associated with the development of necrotizing enterocolitis
(NEC), a serious intestinal disease and major cause of death in preterm neonates. Our long-term objective is to
identify key mechanisms that regulate anemia-induced alterations in neonatal immunity that contribute to gut
inflammation and injury and thus may predispose neonates to inflammatory conditions such as NEC. Our central
hypothesis is that variability in anemia-induced alterations in immunosuppressive erythroid progenitors (IEPs)
and hypoxia-induced inflammation can differentially impact immune function in the gut, directly predisposing
neonates to gut injury that may cause NEC. Our hypothesis is formulated on the basis of our recent discovery
that severe anemia in preterm infants can result in impaired gut oxygenation, as measured by near infrared
spectroscopy (NIRS), and significantly increased serum levels of pro-inflammatory interferon gamma (IFNg).
Using a preclinical model, our data also demonstrate that anemia drives IFNg production by intestinal
macrophages that induces intestinal injury, consistent with previous studies that demonstrate that IFNg can
directly compromise epithelial barrier function. Importantly, anemia also induces the development of erythroid
progenitors, which not only possess the ability to facilitate increased red blood cell (RBC) production, but also
appear to be intrinsically immunosuppressive. Consistent with this, IEPs isolated from cord blood possess the
ability to suppress macrophage activation, while removal of IEPs in our pre-clinical model exacerbates anemia-
induced gut macrophage activation and intestinal injury. Taken together, these results suggest that individual
variation in the hypoxic response to lower Hb values, coupled with alterations in anemia-induced IEP numbers
and function, creates imbalances that alter local macrophage activity leading to distinct responses in the gut that
predispose neonates to intestinal inflammation and place them at higher risk of NEC. To test our central
hypothesis, we will pursue the following specific aims: Aim 1: Define the correlation between anemia and its
treatment on IEP number and function, and how these relate to serum cytokines, pro-inflammatory monocyte
differentiation, and markers of intestinal oxygenation, inflammation, and injury. Aim 2: Define the impact of
anemia-induced IEPs on macrophage pro-inflammatory cytokine secretion, intestinal inflammation and injury
following different thresholds, durations and treatments of anemia in a pre-clinical model. We think these aims
provide a unique opportunity to define key factors that regulate anemia-induced alterations in intestinal
inflammation and injury. In doing so, these data possess the capacity to provide important insight into the global
immune impact of anemia on neonatal intestinal injury that may contribute to NEC.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Impact of Anemia and Its Treatment on Gut Injury in Preterm Infants
-
批准号:10915774
-
项目类别:
-
资助金额:$13.78万
-
财政年份:2023
-
负责人:CASSANDRA D JOSEPHSON
-
依托单位:
Impact of Anemia and Its Treatment on Gut Injury in Preterm Infants
-
批准号:10453723
-
项目类别:
-
资助金额:$61.22万
-
财政年份:2020
-
负责人:CASSANDRA D JOSEPHSON
-
依托单位:
Impact of Anemia and Its Treatment on Gut Injury in Preterm Infants
-
批准号:10630548
-
项目类别:
-
资助金额:$13.78万
-
财政年份:2020
-
负责人:CASSANDRA D JOSEPHSON
-
依托单位:
Impact of Anemia and Its Treatment on Gut Injury in Preterm Infants
-
批准号:10035140
-
项目类别:
-
资助金额:$61.22万
-
财政年份:2020
-
负责人:CASSANDRA D JOSEPHSON
-
依托单位:
MASSIVE TRANSFUSION EPIDEMIOLOGY AND OUTCOMES IN CHILDREN (MATIC) STUDY
-
批准号:9319302
-
项目类别:
-
资助金额:$23.59万
-
财政年份:2016
-
负责人:CASSANDRA D JOSEPHSON
-
依托单位:
MASSIVE TRANSFUSION EPIDEMIOLOGY AND OUTCOMES IN CHILDREN (MATIC) STUDY
-
批准号:9182482
-
项目类别:
-
资助金额:$19.78万
-
财政年份:2016
-
负责人:CASSANDRA D JOSEPHSON
-
依托单位:
Project 2: RBC Irradiation and Anemia Trigger Gut Injury in Preterm Infants
-
批准号:8794966
-
项目类别:
-
资助金额:$35.26万
-
财政年份:2008
-
负责人:CASSANDRA D JOSEPHSON
-
依托单位:
Pediatric Transfusion Medicine Academic Career Award
-
批准号:7473097
-
项目类别:
-
资助金额:$11.88万
-
财政年份:2007
-
负责人:CASSANDRA D JOSEPHSON
-
依托单位:
Pediatric Transfusion Medicine Academic Career Award
-
批准号:8079070
-
项目类别:
-
资助金额:$11.88万
-
财政年份:2007
-
负责人:CASSANDRA D JOSEPHSON
-
依托单位:
Pediatric Transfusion Medicine Academic Career Award
-
批准号:7849551
-
项目类别:
-
资助金额:$11.88万
-
财政年份:2007
-
负责人:CASSANDRA D JOSEPHSON
-
依托单位:
Pediatric Transfusion Medicine Academic Career Award
-
批准号:7281894
-
项目类别:
-
资助金额:$11.88万
-
财政年份:2007
-
负责人:CASSANDRA D JOSEPHSON
-
依托单位:
Pediatric Transfusion Medicine Academic Career Award
-
批准号:7632186
-
项目类别:
-
资助金额:$11.88万
-
财政年份:2007
-
负责人:CASSANDRA D JOSEPHSON
-
依托单位:
Transfusion Medicine/Hemostasis Clinical Trails Network
-
批准号:7928798
-
项目类别:
-
资助金额:$15.57万
-
财政年份:2002
-
负责人:CASSANDRA D JOSEPHSON
-
依托单位:
Transfusion Medicine/Hemostasis Clinical Trails Network
-
批准号:8136526
-
项目类别:
-
资助金额:$19.13万
-
财政年份:2002
-
负责人:CASSANDRA D JOSEPHSON
-
依托单位:
Transfusion Medicine/Hemostasis Clinical Trails Network
-
批准号:7681050
-
项目类别:
-
资助金额:$19.13万
-
财政年份:2002
-
负责人:CASSANDRA D JOSEPHSON
-
依托单位:
Project 2
-
批准号:10215594
-
项目类别:
-
资助金额:$38.43万
-
财政年份:1992
-
负责人:CASSANDRA D JOSEPHSON
-
依托单位:
Project 2
-
批准号:10465081
-
项目类别:
-
资助金额:$38.43万
-
财政年份:1992
-
负责人:CASSANDRA D JOSEPHSON
-
依托单位:
Project 2
-
批准号:9767266
-
项目类别:
-
资助金额:$38.43万
-
财政年份:--
-
负责人:CASSANDRA D JOSEPHSON
-
依托单位:
国内基金
海外基金
基于构建骨骼类器官模型探究Fanconi anemia信号通路调控电刺激诱导神经化成骨过程的机制研究
-
批准号:82302715
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:熊泽康
-
依托单位:
FANCM蛋白在传统Fanconi anemia通路以外对保护基因组稳定性的功能
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2021
-
负责人:陈英伟
-
依托单位:
范可尼贫血(Fanconi Anemia)基因FANCM在复制后修复中的作用及FA癌症抑制通路的机制研究
-
批准号:31200592
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2012
-
负责人:孙伟力
-
依托单位: